2022
DOI: 10.1016/j.amjcard.2022.01.030
|View full text |Cite
|
Sign up to set email alerts
|

Serial Assessment of Myocardial Injury Markers in Mechanically Ventilated Patients With SARS-CoV-2 (from the Prospective MaastrICCht Cohort)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 12 publications
(9 citation statements)
references
References 28 publications
1
8
0
Order By: Relevance
“…Our finding of adverse COVID-19 outcomes associated with myocardial injury based on serial high-sensitivity cardiac troponin assessment is in line with existing evidence [21] , [22] , [23] , [24] and underscores the value of serial cardiac troponin measurements in patients with COVID-19. However, current evidence is limited by the definitions of myocardial injury employed, lack of data on serial testing and thereby dynamic cardiac troponin changes, use of inconsistent sampling intervals, and use of non-high-sensitivity assays [12] .…”
Section: Discussionsupporting
confidence: 89%
See 1 more Smart Citation
“…Our finding of adverse COVID-19 outcomes associated with myocardial injury based on serial high-sensitivity cardiac troponin assessment is in line with existing evidence [21] , [22] , [23] , [24] and underscores the value of serial cardiac troponin measurements in patients with COVID-19. However, current evidence is limited by the definitions of myocardial injury employed, lack of data on serial testing and thereby dynamic cardiac troponin changes, use of inconsistent sampling intervals, and use of non-high-sensitivity assays [12] .…”
Section: Discussionsupporting
confidence: 89%
“…Besides isolated myocardial injury or type 2 myocardial infarction, such elevations may be indicative of myocarditis or type 1 myocardial infarction and may further be associated with both increased disease severity and mortality [10] , [11] , [12] , [13] , [14] , [15] . While serial cardiac troponin testing plays crucial diagnostic and prognostic roles among patients presenting with acute-onset chest pain [16] , [17] , [18] , [19] , [20] , evolving data also suggest that serial troponin assessment may improve prognostic stratification in patients with COVID-19 [21] , [22] , [23] , [24] .…”
Section: Introductionmentioning
confidence: 99%
“…The Maastricht Intensive Care COVID (MaastrICCht) cohort study design has been described more extensively elsewhere [33][34][35][36] This study included all participants with respiratory insu ciency requiring mechanical ventilation and at least one positive PCR test for SARS-CoV-2 and/or a chest CT scan strongly suggestive of SARS-CoV-2 infection, based on a CORADS-score of 4-5 37 . Participants were followed from the moment of intubation until the primary outcome (death during ICU admission or discharge from the ICU).…”
Section: Study Design and Populationmentioning
confidence: 99%
“…This makes patients at inclusion to be assumed at similar time-points of disease and severity during their COVID-19 disease, i.e., an inception cohort. In addition, this allows us to take all observations into account over time, also if a patient is transported after intubation from another ICU, facilitating the investigation of the development of variables over time 34,35,40 .…”
Section: Study Design and Populationmentioning
confidence: 99%
“…Furthermore, Troponin-T and Troponin-I could have prognostic value in pulmonary diseases such as pneumonia and chronic obstructive pulmonary disease 40 . A serial assessment can identify factors predicting cardio-circulatory damage or mortality in ECMO but with a lower prognostic value compared to lactate 39,41 .…”
Section: Bnp Nt-pro-bnp and Troponinmentioning
confidence: 99%